Related Experiment Video
Updated: Feb 14, 2026

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines
Roman C Brands1,2, Mario J J Scheurer1, Stefan Hartmann1,3
1Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, D-97070 Würzburg, Germany.
Abstract:
Inhibitor of apoptosis proteins, which are overexpressed in head and neck squamous cell carcinoma (HNSCC), may cause therapeutic resistance. Using SMAC mimetic compounds, including birinapant, to degrade and/or inhibit these proteins and sensitize apoptosis may enhance therapies in HNSCC. Fas expression was analyzed in nine HNSCC cell lines and one keratinocyte cell line via flow cytometry. These cell lines were treated with Fas ligand-Fc (FasL) and birinapant, a bivalent SMAC mimetic, in mono and combination therapies. Cytotoxicity was measured using a crystal violet assay. Annexin V assay was performed for detection of apoptosis. The treatment efficacy of mono and combination therapies was statistically analyzed. Nonlinear regression analysis was performed to determine the inhibitory concentration (IC10) of birinapant. Fas expression was detected in each cell line tested. Mono treatment with FasL revealed minor to no apoptotic effects in the majority of the cell lines. Crystal violet and Annexin V staining revealed increased apoptosis rates for all cell lines following incubation with birinapant in mono treatment. Combination treatment with FasL and birinapant (IC10) revealed additional and synergistic effects in eight out of the ten cell lines. To the best of our knowledge, the present study provided the first evidence of the apoptosis-sensitizing activity of combination treatment with FasL and birinapant in HNSCC cell lines.
Insights
This study shows that combining birinapant with Fas ligand enhances apoptosis in head and neck squamous cell carcinoma (HNSCC) cells. This combination therapy offers a promising strategy to overcome therapeutic resistance in HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Inhibitor of apoptosis proteins (IAPs) are overexpressed in head and neck squamous cell carcinoma (HNSCC), contributing to therapeutic resistance.
- SMAC mimetic compounds, like birinapant, can degrade or inhibit IAPs, potentially sensitizing cancer cells to apoptosis and enhancing treatment efficacy.
Purpose of the Study:
- To investigate the efficacy of combining birinapant with Fas ligand (FasL) in sensitizing HNSCC cell lines to apoptosis.
- To evaluate the synergistic effects of this combination therapy on HNSCC cell cytotoxicity.
Main Methods:
- Fas expression was analyzed in HNSCC cell lines using flow cytometry.
- Cell lines were treated with FasL and birinapant (a bivalent SMAC mimetic) in mono and combination therapies.
- Cytotoxicity was assessed via crystal violet assay, and apoptosis was measured using Annexin V staining.
Main Results:
- Fas expression was detected in all tested HNSCC cell lines.
- Birinapant monotherapy increased apoptosis rates across all cell lines.
- Combination treatment with FasL and birinapant (at IC10) demonstrated additional and synergistic apoptotic effects in 80% of the HNSCC cell lines.
Conclusions:
- This study provides the first evidence of apoptosis-sensitizing activity of combined FasL and birinapant treatment in HNSCC cell lines.
- The combination of birinapant and FasL shows potential as a novel therapeutic strategy to overcome resistance in HNSCC.
More Related Videos
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Cell Lines
Apoptosis
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Adult Stem Cells

